Delivery Order SPE2DB25D3022-SPE2DB25FWBTC
- Not listed
- The Defense Logistics Agency awarded a $33,900.30 delivery order to AmerisourceBergen Drug Corp for IMOVAX Rabies Vaccine vials on June 5, 2025, with an ultimate completion date of June 6, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.75 to AmerisourceBergen Drug Corp for IMOVAX Rabies Vaccine vials, with a completion date of September 9, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement supporting military and veteran healthcare systems. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of IMOVAX Rabies Vaccine vials on September 10, 2025. This competitively awarded, firm fixed-price contract carries a ceiling value of $2,286.87 and has an ultimate completion date of September 11, 2025. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $8,032.44 to AmerisourceBergen Drug Corp for the supply of IMOVAX Rabies Vaccine Vials. This firm fixed price contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a routine medical supply procurement with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,568.75 for IMOVAX Rabies Vaccine vials on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price contract, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $33,412.50 to AmerisourceBergen Drug Corp for the supply of IMOVAX Rabies Vaccine Vials. This firm fixed-price contract, awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a competitively awarded, non-set-aside procurement with performance conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,376.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of IMOVAX Rabies Vaccine vials. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), requires completion by July 28, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $33,412.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Imovax Rabies Vaccine vials, with an ultimate completion date of September 25, 2025. The award was made on September 24, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $10,023.75 to AmerisourceBergen Drug Corp for IMOVAX Rabies Vaccine Vials. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The vaccine delivery is scheduled for completion by September 23, 2025, with performance at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $2,673.00 delivery order to AmerisourceBergen Drug Corp for IMOVAX Rabies Vaccine Vials on September 19, 2025, with an ultimate completion date of September 22, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The vaccine will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- SPE2DB25D3022Indefinite Delivery Contract
- SPE2DB25D3022-SPE2DB25FWBTCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,336.50 to AmerisourceBergen Drug Corp for IMOVAX Rabies Vaccine vials, with an ultimate completion date of June 18, 2025. This is a firm fixed price, non-set-aside contract issued on June 17, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs across the Defense Health System. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including vaccines, specialty medications, and critical medical commodities. The company's demonstrated capability to fulfill federal medical supply requirements through competitive procurement is reflected in its extensive portfolio of contract awards with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 6/17/25 |